• The rate of neurodegenerative conditions is growing globally, meaning that a lot of research is into prevention of these problems.
• There has been some research suggesting that a type of type 2 diabetes drugs called SGLT2 inhibitors could reduce the incidence of some neurodegenerative conditions including Parkinson’s disease and Alzheimer’s disease.
• Now, a large cohort study has shown use of these drugs is associated with a lower risk of developing these neurodegenerative conditions.

Written by Hannah Flynn on September 19, 2024 — Fact checked by Jill Seladi-Schulman, Ph.D.

read full article